A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

NCT01776307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: BBI608
DRUG: Panitumumab
DRUG: Capecitabine
DRUG: Cetuximab

Sponsor

Sumitomo Pharma America, Inc.